The efficacy of n-acetylcysteine in preventing contrast-induced nephropathy in type 2 diabetic patients without nephropathy

Journal of Nephrology

Volumn 23, Issue 4, 2010, Pages 478-482

  Sar, Fuat ^a   Saler, Tayyibe ^a   Ecebay, Alphan ^a   Saglam, Zuhal A ^a   Ozturk, Savas ^a   Kazancioglu, Rumeyza ^a  

^a HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Contrast media; Diabetes mellitus; N acetyl cystein; Nephropathy

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; IOHEXOL; METFORMIN; ORAL ANTIDIABETIC AGENT; SODIUM CHLORIDE; CONTRAST MEDIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTRAST INDUCED NEPHROPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC PATIENT; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; AGED; CHEMICALLY INDUCED; COMPLICATION; DIABETIC NEPHROPATHIES; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ACETYLCYSTEINE; ADULT; AGED; CONTRAST MEDIA; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 77955436635     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Van Dam PS, Van Asbeck BS, Erkelens DW, Marx JJ, Gispen WH, Bravenboer B. The role of oxidative stress in neuropathy and other diabetic complications. Diabetes Metab Rev. 1995;11:181-192.
2. Bukan N, Sancak B, Yavuz Ö, et al. Lipid peroxidation and scavenging enzyme levels in the liver of streptozotocin- induced diabetes rats. Indian J Biochem Biophys. 2003;40:447-450. (Pubitemid 39360689)
3. Bonnefont-Rousselot D. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care. 2002;5:561-568.
4. Erley CM. Nephrotoxicity: focusing on radiocontrast nephropathy. Nephrol Dial Transplant. 1999;14 Suppl 4:5-13.
5. Erley CM, Bader BD. Consequences of intravascular contrast media on kidney function risk and prevention. Rofo. 2000;172:791-797.
6. Cronin RE. Renal failure following radiologic procedures. Am J Med. 1989;298:342-356.
7. Quader MA, Sawmiller C, Sumpio BA. Contrast-induced nephropaty: review of incidence and pathophysiology. Ann Vasc Surg. 1998;12:612-620.
8. Hou SH, Bushinsky DA, Wish JB, et al. Hospital-aquired renal insufficiency:a prospective study. Am J Med. 1983;74:243-248. (Pubitemid 13192180)
9. Pinto CF, Watanabe M, Vattimo Mde F. Hydration and N- acetylcysteine in acute renal failure caused by iodinated contrast medium: an experiment with rats. J Nephrol. 2008;21:783-788.
10. Tadros GM, Mouhayar EN, Akinwande AO, et al. Prevention of radiocontrast-induced nephropathy with N-acetylcysteine in patients undergoing coronary angiography. J Invasive Cardiol. 2003;15:311-314.
11. Tepel M, Van Del Giet M, Schwarzfeld NR, et al. Prevention of radiographic contrast agent induced reductions in renal function by acetylcystein. N Engl J Med. 2000;343:180-184.
12. Birck R, Krzossok S, Markowetz F, Schnülle P, van der Woude FJ, Braun C. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet. 2003;362:589-603.
13. Boccalandro F, Amhad M, Smalling RW, Sdringola S. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast. Catheter Cardiovasc Interv. 2003;58:342-343.
14. Briguori C, Manganelli F, Scarpato P, et al. Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol. 2002;40:298-303.
15. Baker CS, Wragg A, Kumar S, et al. A rapid protocol for the preventing of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol. 2003;41:2114-2118. (Pubitemid 36724254)
16. Briguori C, Colombo A, Violante A, et al. Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J. 2003;3:206-211.
17. Reddan D, Laville M, Garovic VD. Contrast-induced nephropathy and its prevention: what do we really know from evidence- based findings? J Nephrol. 2009;22:333-351.